share_log

Cingulate | 4: Statement of changes in beneficial ownership of securities-Officer Brams Matthew

Cingulate | 4: Statement of changes in beneficial ownership of securities

Cingulate | 4：持股變動聲明
美股sec公告 ·  04/01 19:03
Moomoo AI 已提取核心訊息
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. [CING], was involved in a transaction on 03/29/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value of shares, were not disclosed in the announcement. The action type and status, as well as the number of shares held after the action, were also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. [CING], was involved in a transaction on 03/29/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value of shares, were not disclosed in the announcement. The action type and status, as well as the number of shares held after the action, were also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Cingulate Inc. [CING] 執行副總裁兼首席醫學官馬修·布拉姆斯於2024年3月29日參與了一筆交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供行動類型和狀態以及行動後持有的股票數量。建議投資者尋求更多信息，以充分了解這一事件對其投資決策的影響。
Cingulate Inc. [CING] 執行副總裁兼首席醫學官馬修·布拉姆斯於2024年3月29日參與了一筆交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供行動類型和狀態以及行動後持有的股票數量。建議投資者尋求更多信息，以充分了解這一事件對其投資決策的影響。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息